Australia Artificial Intelligence In Drug Repurposing Market Size & Outlook

Name: Australia Artificial Intelligence In Drug Repurposing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The artificial intelligence in drug repurposing market in Australia is expected to reach a projected revenue of US$ 220.7 million by 2033. A compound annual growth rate of 27.1% is expected of Australia artificial intelligence in drug repurposing market from 2026 to 2033.

Australia artificial intelligence in drug repurposing component outlook (Revenue, USD million, 2021-2033)
- Software & Platform
- Services
Australia artificial intelligence in drug repurposing application outlook (Revenue, USD million, 2021-2033)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Rare & Orphan Diseases
- Other Therapeutic Areas
Australia artificial intelligence in drug repurposing technology outlook (Revenue, USD million, 2021-2033)
- Machine Learning/Deep Learning
- Natural Language Processing (NLP)
- Knowledge Graphs & Network-Based AI
- Generative AI & Large Language Models (LLMs)
- Computer Vision
Australia artificial intelligence in drug repurposing end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Other End Use

Australia Artificial Intelligence In Drug Repurposing Market Size & Outlook

Sign up - it's easy, and free!